Market capitalization | $4.78m |
Enterprise Value | $-19.98m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 1.22 |
P/B ratio (TTM) P/B ratio | 0.20 |
Revenue (TTM) Revenue | $0.00 |
EBIT (operating result TTM) EBIT | $-17.86m |
Free Cash Flow (TTM) Free Cash Flow | $-16.44m |
Cash position | $24.76m |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
2 Analysts have issued a Check-Cap Ltd. forecast:
2 Analysts have issued a Check-Cap Ltd. forecast:
Dec '23 |
+/-
%
|
||
Revenue | - - |
-
|
|
Gross Profit | -0.21 -0.21 |
-
|
|
EBITDA | -18 -18 |
-
|
EBIT (Operating Income) EBIT | -18 -18 |
-
|
Net Profit | -18 -18 |
-
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Check-Cap Ltd. is a clinical stage medical diagnostics company engaging in the development of ingestible imaging capsule system for colorectal cancer screening. The company was founded by Yoav Kimchy in 2005 and is headquartered in Isfiya, Israel.
Head office | Israel |
CEO | Saar Levi |
Founded | 2005 |
Website | www.check-cap.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.